The researchers observed that among the 3-year survivors, 39 were women, 61had left-sided tumor, and the average age was 56 years. In fact, more of the survivors were at the average age or younger, were women, had a tumor made up of epithelial pleural mesothelioma. cells, and/or had normal white blood cell count, hemoglobin, or platelet count before the operation.
The average survival time of the 117 patients who survived for three years or more was 59 months. However, the researchers noted that a significant association between age and survival was found for women. No such association existed for men who underwent extrapleural pneumonectomy.
“A significant proportion of patients undergoing extrapleural pneumonectomy for pleural mesothelioma experienced extended survival. Although favorable prognostic features were more common, the cohort of 3-year survivors included a substantial number of pleural mesothelioma. patients with late-stage disease. The longest survival (median greater than 7 years) was experienced by women under the median age of 56 years.”
They also felt that the evidence supported the use of extrapleural pneumonectomy for debulking a large portion of the tumor as part of a multimodality therapy, meaning using more than one treatment, to extend survival for malignant pleural mesothelioma.
The researchers observed that among the 3-year survivors, 39 were women, 61had left-sided tumor, and the average age was 56 years. In fact, more of the survivors were at the average age or younger, were women, had a tumor made up of epithelial cells, and/or had normal white blood cell count, hemoglobin, or platelet count before the operation.
No comments:
Post a Comment